日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk

最初诊断为非高危神经母细胞瘤但最终发展为高危临床病程的分子特征

Bruinsma, Rixt S; de Leng, Wendy W J; Fiocco, Marta F; Dierselhuis, Miranda P; Langenberg, Karin P; Molenaar, Jan J; Kester, Lennart A; van Noesel, Max M; Tytgat, Godelieve A M; van de Ven, Cornelis P; Wijnen, Marc H W A; de Krijger, Ronald R; Steeg, Alida F W van der

Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma

绘制B细胞图谱和三级淋巴结构的免疫图谱揭示了它们在神经母细胞瘤中的临床意义

Melaiu, Ombretta; Chierici, Marco; Gragera, Paula; Lazzaro, Nicolò; Petrilli, Lucia L; Wienke, Judith; Bergsma, Francisca J; Verhoeven, Bronte Manouk; De Stefanis, Cristiano; D'Oria, Valentina; Benedetti, Maria C; Barillari, Giovanni; Alaggio, Rita; De Ioris, Maria Antonietta; Vinci, Maria; Baryawno, Ninib; Carsetti, Rita; Jurman, Giuseppe; Molenaar, Jan J; Locatelli, Franco; Fruci, Doriana

Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325]

对“将儿科精准肿瘤学应用于临床实践:儿童癌症个体化治疗计划‘iTHER’”的更正[Eur J Cancer 175 (2022) 311-325]

Langenberg, Karin P S; Meister, Michael T; Bakhuizen, Jette J; Boer, Judith M; van Eijkelenburg, Natasha K A; Hulleman, Esther; Ilan, Uri; Looze, Eleonora J; Dierselhuis, Miranda P; Lugt, Jasper van der; Breunis, Willemijn; Schild, Linda G; Ober, Kimberley; van Hooff, Sander R; Scheijde-Vermeulen, Marijn A; Hiemcke-Jiwa, Laura S; Flucke, Uta E; Kranendonk, Mariette E G; Wesseling, Pieter; Sonneveld, Edwin; Punt, Simone; Boltjes, Arjan; van Dijk, Freerk; Verwiel, Eugene T P; Volckmann, Richard; Hehir-Kwa, Jayne Y; Kester, Lennart A; Koudijs, Marco M J; Waanders, Esme; Holstege, Frank C P; Vormoor, H Josef; Hoving, Eelco W; Noesel, Max M van; Pieters, Rob; Kool, Marcel; Stumpf, Miriam; Blattner-Johnson, Mirjam; Balasubramanian, Gnana P; Van Tilburg, Cornelis M; Jones, Barbara C; Jones, David T W; Witt, Olaf; Pfister, Stefan M; Jongmans, Marjolijn C J; Kuiper, Roland P; de Krijger, Ronald R; Wijnen, Marc H W; den Boer, Monique L; Zwaan, C Michel; Kemmeren, Patrick; Koster, Jan; Tops, Bastiaan B J; Goemans, Bianca F; Molenaar, Jan J

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine

在精准医疗时代,探索神经母细胞瘤细胞系和患者来源的肿瘤类器官中的高通量药物敏感性检测

Langenberg, Karin P S; van Hooff, Sander R; Koopmans, Bianca; Strijker, Josephine G M; Kholosy, Waleed M; Ober, Kimberley; Zwijnenburg, Danny A; van der Hoek, Jessica J F; Keller, Kaylee M; Vernooij, Lindy; Schild, Linda G; Looze, Eleonora J; Ebus, Marli E; Essing, Anke H W; Vree, Paula de; Tas, Michelle L; Matser, Yvette A H; Wienke, Judith; Volckmann, Richard; Tops, Bastiaan B J; Kester, Lennart A; Badloe, Shashi; Hehir-Kwa, Jayne Y; Kemmeren, Patrick; Goemans, Bianca F; Zwaan, C Michel; Oehme, Ina; Jäger, Nathalie; Witt, Olaf; van Eijkelenburg, Natasha K A; Dierselhuis, Miranda P; Tytgat, Godelieve A M; Wijnen, Marc H W; van Noesel, Max M; de Krijger, Ronald R; Eising, Selma; Koster, Jan; Dolman, Emmy M; Molenaar, Jan J

Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma.

抑制MIF分泌可增强CAR T细胞对神经母细胞瘤的疗效

Strijker Josephine G M, Pascual-Pasto Guillem, Grothusen Grant P, Kalmeijer Yannine J, Kalaitsidou Elisavet, Zhao Chunlong, McIntyre Brendan, Matlaga Stephanie, Visser Lindy L, Barisa Marta, Himsworth Courtney, Shah Rivani, Muller Henrike, Schild Linda G, Hains Peter G, Zhong Qing, Reddel Roger R, Robinson Phillip J, Catena Xavier, Soengas María S, Margaritis Thanasis, Dekker Frank J, Anderson John, Molenaar Jan J, Bosse Kristopher R, Wu Wei, Wienke Judith

γδ T cells are the prime antitumoral T cells in pediatric neuroblastoma

γδ T 细胞是儿童神经母细胞瘤中的主要抗肿瘤 T 细胞。

Castenmiller, Suzanne M; Borst, Anne L; Wardak, Leyma; Molenaar, Jan J; Papadopoulou, Maria; de Krijger, Ronald R; van der Steeg, Alida Fw; van Noesel, Max M; Vermijlen, David; de Groot, Rosa; Wienke, Judith; Wolkers, Monika C

Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out

抗癌化合物筛选发现,抑制 Aurora 激酶 A 可作为一种手段,使 CRISPR/Cas9 基因编辑优于基因敲除。

Wilbie, Danny; Eising, Selma; Amo-Addae, Vicky; Walther, Johanna; Bosman, Esmeralda; Lei, Zhiyong; de Jong, Olivier G; Molenaar, Jan J; Mastrobattista, Enrico

Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.

肝母细胞瘤肿瘤和类器官中 WNT 信号传导和药物敏感性特征的差异

Kluiver Thomas A, Lu Yuyan, Schubert Stephanie A, Kraaier Lianne J, Ringnalda Femke, Lijnzaad Philip, DeMartino Jeff, Megchelenbrink Wouter L, Amo-Addae Vicky, Eising Selma, de Faria Flavia W, Münter Daniel, van de Wetering Marc, Kerl Kornelius, Duiker Evelien, van den Heuvel Marius C, de Meijer Vincent E, de Kleine Ruben H, Molenaar Jan J, Margaritis Thanasis, Stunnenberg Hendrik G, de Krijger Ronald R, Zsiros József, Clevers Hans, Peng Weng Chuan

Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience

儿童血液癌症患者匹配治疗的致癌和免疫靶点:荷兰 iTHER 研究经验

Boer, Judith M; Ilan, Uri; Boeree, Aurélie; Langenberg, Karin P S; Koster, Jan; Koudijs, Marco J; Hehir-Kwa, Jayne Y; Nierkens, Stefan; Rossi, Corinne; Molenaar, Jan J; Goemans, Bianca F; den Boer, Monique L; Zwaan, C Michel

Complex structural variation is prevalent and highly pathogenic in pediatric solid tumors

复杂的结构变异在儿童实体瘤中普遍存在,且具有高度致病性。

van Belzen, Ianthe A E M; van Tuil, Marc; Badloe, Shashi; Janse, Alex; Verwiel, Eugène T P; Santoso, Marcel; de Vos, Sam; Baker-Hernandez, John; Kerstens, Hindrik H D; Solleveld-Westerink, Nienke; Meister, Michael T; Drost, Jarno; van den Heuvel-Eibrink, Marry M; Merks, Johannes H M; Molenaar, Jan J; Peng, Weng Chuan; Tops, Bastiaan B J; Holstege, Frank C P; Kemmeren, Patrick; Hehir-Kwa, Jayne Y